Equity Analyst, LightStream Research

Oshadhi Kumarasiri

An equity research analyst with over 7 years of experience in multiple sectors. Previously worked for one of the world's largest asset managers with about USD2.5trn in AUM, covering small and micro-cap companies in the consumer sphere across Europe and developed Asia. Also experienced in covering multiple industries including banking, insurance and asset management, retail, tech, telco and REIT.

Equity Analyst

Long-Short Analysis on Japan, Asia and the World

LightStream Research

LightStream conducts quantitatively rigorous and data-driven analysis with a focus on Japan and Asia.

We consistently cover the Tech, Consumer and Industrial sectors, and provide ECM and Events coverage more broadly.

We supplement traditional qualitative insights from company relationships with a robust quantitative foundation that examines as much historical data as is available.
We further refine the accuracy of our insights and calls through the use of alternative data to flesh out current trends, and through a valuation framework that emphasises non-superficial peer group selection and a proper attempt to understand the metrics and changes that have driven security valuations in the past.

Equity Capital Markets

China Pacific Insurance / Equity Capital Markets

<a href="https://www.smartkarma.com/entities/china-pacific-insurance-group" target="_blank" data-smartkarma-citation="entities:6177:1" rel="noopener">China Pacific Insurance (Group) Co., (2601 HK)</a> received shareholder approval to raise capital through a foreign listing in September 2019. Yesterday (3rd June 2020) the company announced that they received approval from the Securities Regulatory Commission of China to issue up to 628.7m new ordinary shares (125.7m GDRs). However, final approvals from the securities regulator of the United Kingdom and London Stock Exchange are still pending.
Furthermore, <a href="https://www.smartkarma.com/entities/swiss-re-ag-1f83dcbc-730e-46fa-82f2-bfe7e8e361a1" target="_blank" data-smartkarma-citation="entities:27914:1" rel="noopener">Swiss Re AG (SREN SW)</a> become a cornerstone investor to the offering and agreed to subscribe up to a maximum of 1.5% of the ordinary share capital (post-placement) with a lock-up period of three years.
We believe the company is likely to raise over $2.6bn via this placement, which will improve the company’s capital adequacy as equity is increased by 10%.

China Pacific Insurance (Group) Co., (2601 HK) received shareholder approval to raise capital through a foreign listing in September 2019. Yesterday (3rd June 2020) the company announced that they received approval from the Securities Regulatory Commission of China to issue up to 628.7m new ordinary shares (125.7m GDRs). However, final approvals from the securities regulator of the United Kingdom and London Stock Exchange are still pending.
Furthermore, Swiss Re AG (SREN SW) become a cornerstone investor to the offering and agreed to subscribe up to a maximum of 1.5% of the ordinary share capital (post-placement) with a lock-up period of three years.
We believe the company is likely to raise over $2.6bn via this placement, which will improve the company’s capital adequacy as equity is increased by 10%.

China Pacific Insurance Receives Approval to Raise Capital Via a Listing on LSE